Telesis Bio (TBIO) Competitors $0.40 +0.05 (+14.29%) As of 02/21/2025 11:28 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends TBIO vs. SMIT, SPEC, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, THMO, TT, and KEYSShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), ThermoGenesis (THMO), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Schmitt Industries Spectaire HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition ThermoGenesis Trane Technologies Keysight Technologies Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership. Does the media refer more to TBIO or SMIT? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score. Company Overall Sentiment Telesis Bio Neutral Schmitt Industries Neutral Does the MarketBeat Community favor TBIO or SMIT? Schmitt Industries received 85 more outperform votes than Telesis Bio when rated by MarketBeat users. Likewise, 55.29% of users gave Schmitt Industries an outperform vote while only 52.94% of users gave Telesis Bio an outperform vote. CompanyUnderperformOutperformTelesis BioOutperform Votes952.94% Underperform Votes847.06% Schmitt IndustriesOutperform Votes9455.29% Underperform Votes7644.71% Do institutionals and insiders have more ownership in TBIO or SMIT? 37.6% of Telesis Bio shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by company insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility and risk, TBIO or SMIT? Telesis Bio has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Is TBIO or SMIT more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Schmitt Industries N/A N/A N/A Which has higher valuation and earnings, TBIO or SMIT? Schmitt Industries has lower revenue, but higher earnings than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$27.51M0.03-$47.72M-$28.20-0.01Schmitt Industries$9.89M0.01-$3.28MN/AN/A SummaryTelesis Bio and Schmitt Industries tied by winning 5 of the 10 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$630,000.00$5.11B$5.82B$9.09BDividend YieldN/A0.45%4.77%3.84%P/E RatioN/A12.2218.9215.38Price / Sales0.033.82453.2984.08Price / CashN/A37.2043.8437.22Price / Book2.862.007.644.65Net Income-$47.72M-$83.57M$3.18B$245.69M7 Day Performance8.11%-2.41%-1.95%-2.67%1 Month Performance33.33%-7.28%-0.23%-2.16%1 Year Performance-95.15%-21.59%16.69%12.90% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.40+14.3%N/A-93.7%$630,000.00$27.51M0.00200Gap DownHigh Trading VolumeSMITSchmitt IndustriesN/A$0.02flatN/AN/A$69,000.00$9.89M0.00160SPECSpectaireN/A$0.00flatN/AN/A$2,000.00N/A0.008HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09+10.4%N/A-18.3%$0.00N/A0.003Gap UpPRENWPrenetics GlobalN/A$0.01+8.1%N/A+66.7%$0.00$25.56M0.001Negative NewsGap DownQSIAWQuantum-SiN/A$0.73-4.6%N/A+220.3%$0.00$2.27M0.00150Negative NewsSMAPWSportsMap Tech AcquisitionN/A$0.07+23.3%N/AN/A$0.00N/A0.00N/AGap UpTHMOThermoGenesisN/AN/AN/AN/A$0.00$9.44M0.0040News CoverageTTTrane Technologies4.415 of 5 stars$363.58+0.6%$415.25+14.2%+28.3%$81.81B$19.84B32.3240,000Positive NewsKEYSKeysight Technologies3.9597 of 5 stars$183.40+2.3%$180.80-1.4%+21.7%$31.71B$4.98B52.4015,500Upcoming EarningsAnalyst UpgradePositive News Related Companies and Tools Related Companies Schmitt Industries Competitors Spectaire Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors ThermoGenesis Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TBIO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
